
IntelGenX
Our business strategy is to apply our proprietary drug delivery technologies to improve existing drug compounds with proven efficacy and.
Market cap
$29.2m
Enterprise value
$45m
Share price
$0.17 IGXT
Authorizing premium user...
Our business strategy is to apply our proprietary drug delivery technologies to improve existing drug compounds with proven efficacy and.